Literature DB >> 15944425

Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma.

Trisha M Shattuck1, William H Westra, Paul W Ladenson, Andrew Arnold.   

Abstract

BACKGROUND: Papillary thyroid carcinoma is frequently multifocal. We investigated whether noncontiguous tumor foci arise from intraglandular metastases from a single primary tumor or originate as unrelated clones derived from independent precursors.
METHODS: Using a polymerase-chain-reaction assay involving the human androgen receptor gene (HUMARA), we analyzed the patterns of X-chromosome inactivation of multiple distinct foci of well-differentiated multifocal papillary thyroid cancer from 17 women.
RESULTS: Multiple thyroid tumor foci from 10 of 17 patients yielded DNA of adequate quality and were heterozygous for the HUMARA polymorphism and hence suitable for analysis. A single X chromosome was inactivated in each focus, consistent with its monoclonality. When the specific monoclonal configurations of each patient's discrete tumor foci were compared, discordant patterns indicative of independent origins were observed among the tumors from five patients; results in the remaining five were consistent with either a shared or independent clonal origin.
CONCLUSIONS: Individual tumor foci in patients with multifocal papillary thyroid cancer often arise as independent tumors. Copyright 2005 Massachusetts Medical Society.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15944425     DOI: 10.1056/NEJMoa044190

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  78 in total

Review 1.  Diagnostic criteria in well-differentiated thyroid carcinomas.

Authors:  Elsa Fonseca; Paula Soares; Manuel Cardoso-Oliveira; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

2.  Clonal analysis of early-stage bilateral papillary thyroid cancer identifies field cancerization.

Authors:  Xingyun Su; Shitu Chen; Kuifeng He; Zhuochao Mao; Jiaying Ruan; Jie Zhou; Xiaodong Teng; Judy Jin; Thomas J Fahey; Weibin Wang; Lisong Teng
Journal:  Endocrine       Date:  2019-02-26       Impact factor: 3.633

Review 3.  Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma.

Authors:  Frederik A Verburg; Markus Dietlein; Michael Lassmann; Markus Luster; Christoph Reiners
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

Review 4.  The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.

Authors:  Scott A Rivkees; Ernest L Mazzaferri; Frederik A Verburg; Christoph Reiners; Markus Luster; Christopher K Breuer; Catherine A Dinauer; Robert Udelsman
Journal:  Endocr Rev       Date:  2011-08-31       Impact factor: 19.871

5.  One should not just read what one believes: the nearly irresolvable issue of producing truly objective, evidence-based guidelines for the management of differentiated thyroid cancer.

Authors:  Markus Dietlein; F A Verburg; M Luster; C Reiners; F Pitoia; H Schicha
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05       Impact factor: 9.236

6.  The prevalence and prognostic value of BRAF mutation in thyroid cancer.

Authors:  Electron Kebebew; Julie Weng; Juergen Bauer; Gustavo Ranvier; Orlo H Clark; Quan-Yang Duh; Daniel Shibru; Boris Bastian; Ann Griffin
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

7.  How many contralateral papillary thyroid carcinomas can be missed?

Authors:  Kwan Ju Lee; Yun Jung Cho; Jeong Goo Kim; Dong Ho Lee
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

8.  Clinicopathologic risk factors for right paraesophageal lymph node metastasis in patients with papillary thyroid carcinoma.

Authors:  Q A Yu; D K Ma; K P Liu; P Wang; C M Xie; Y H Wu; W J Dai; H C Jiang
Journal:  J Endocrinol Invest       Date:  2018-03-17       Impact factor: 4.256

9.  Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area.

Authors:  Celestino P Lombardi; Rocco Bellantone; Carmela De Crea; Nunzia C Paladino; Guido Fadda; Massimo Salvatori; Marco Raffaelli
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

10.  Geographical mapping of a multifocal thyroid tumour using genetic alteration analysis & miRNA profiling.

Authors:  Sinéad T Aherne; Paul C Smyth; Richard J Flavin; Susan M Russell; Karen M Denning; Jing Huan Li; Simone M Guenther; John J O'Leary; Orla M Sheils
Journal:  Mol Cancer       Date:  2008-12-04       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.